Navigation Links
PA Governor Rendell Says Pennsylvania Again Leads the Nation With Introduction of Chronic Care Management Plan
Date:2/13/2008

HARRISBURG, Pa., Feb. 13 /PRNewswire-USNewswire/ -- Governor Edward G. Rendell today received a blueprint that will save the health care system in Pennsylvania billions of dollars as the commonwealth becomes the national leader in the way it delivers and pays for treatment of chronic diseases while significantly improving care.

The Chronic Care Management, Reimbursement and Cost Reduction Commission delivered its first report to the Governor today as part of the Governor's Prescription for Pennsylvania health care reform plan.

"Chronic diseases are the leading cause of death and disability in Pennsylvania and account for 80 percent of our health care costs," Governor Rendell said. "Our present system treats acute illness; it doesn't control chronic disease. And, faced with the increasing cost of health care, governments, businesses, insurers and Pennsylvania families have -- out of necessity -- chosen to limit health care services.

"In Pennsylvania, only 56 percent of people with a chronic condition receive the recommended care to manage their disease. Unfortunately, evidence is mounting that exactly the opposite approach is more successful.

"The good news is that we know that if health care providers adopt evidence-based protocols proven to help manage chronic disease, it will have long-term health benefits for people. It will also have economic benefits as healthier employees mean improved productivity for our businesses and taking appropriate preventative measures can reduce the need for many expensive emergency room visits and translates to lower insurance premiums overall. That's why this report -- this blueprint -- is critical for improving quality of life and to save money."

The 44 members of the Chronic Care Management, Reimbursement and Cost Reduction Commission have worked since last September to develop a plan that proposes a pilot program enrolling 30-60 primary care practices in the southeastern region
'/>"/>

SOURCE Pennsylvania Office of the Governor
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. National Lt. Governors Association Endorses HERO Campaign; 1st National Association of State Elected Officials Supporting Grassroots Designated Driving Program
2. Governor Rendell Says 2008-09 Budget Renews Commitment to Vulnerable Pennsylvanians
3. Pennsylvania Governor Rendell Announces $1.8 Million Investment to Add Nurses, Improve Nurse Education Grants Awarded to Recipients in 28 Counties
4. The Childrens Aid Society Endorses Critical Components of Governor Spitzers Proposed 2008-2009 State Budget
5. Governor Rendell Offers Coverage to 29,000 on AdultBasic Waiting List; Unveils New Policy to Improve Quality of Care for the Low-Income and Pennsylvanians With Disabilities
6. Governor Rendell Lauds Rebirth of Drug Manufacturing Plant in Danville Area
7. Governor Rendell Directs Insurance Commissioner to Delay Mcare Abatement Collection
8. got breakfast?(TM) Foundation Issues Statement on Recently Released Florida State Plan of Action from the Governors Council on Physical Fitness
9. Presidential Candidate and Former Arkansas Governor Mike Huckabee to Be Keynote Speaker for Hope International Universitys Celebrate Hope Dinner at Disneyland(R) Hotel
10. Governor Rendell Says Funds Are Within Reach to Cover the Uninsured, Continue Mcare Abatement Program
11. AARP Urges Governor to Use Budget to Improve New Yorkers Quality of Life
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/9/2009).../PRNewswire-FirstCall/ - Hard to Treat Diseases (H...ntly completed a merger with Slavica Bio Chem (For... billion shares to pay for the Slavica merger and ...or Slavica is 300 million non-dilatable restricted...lved in Belgrade Serbia research. Key medical cons...
(Date:1/8/2009)...ire/ -- New York City Mayor Michael R. Bloomberg d..." and presented a proclamation to Ilchi Lee, presi...iation) and developer of Brain Education, a revolu...alth, well-being, and mental ability for all ages....ding the power of individuals to change themselves...
(Date:1/8/2009)...e/ -- A study released this week showing that a gr...ple chronic diseases shines a much-needed spotligh... to one that focuses on primary and secondary prev... leader in disease prevention. , , (Logo: h...9LOGO ) , , The study, conducted by Social &a...
(Date:1/8/2009)...enator Daschle at his confirmation hearing to be t... , , WASHINGTON, Jan. 8 /PRNewswire-USNewswire/...member Senator Tom Daschle, nominee for Department...duced by fellow BPC founder and friend Senator Bob...ng was convened by the Senate Health, Education, L...
Breaking Medicine News(10 mins):Health News:Hard To Treat Diseases (HTDS) Recapitalization 2Health News:NYC Mayor Michael R. Bloomberg Declares January 8th 'IBREA Brain Education Day' 2Health News:U.S. Preventive Medicine: Chronic Disease Study Demonstrates Need for Focus on Primary and Secondary Prevention 2Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 2Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 3Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 4
...gic reaction caused to many human beings. A new Ma...// allergic contact dermatitis. The exact definiti...ammation resulting in swollen, reddened and itchy ...rgen. The ten allergens identified by the mayo st...
...y foods seemed to score less in nutrition value be...nutrients, // like iron and protein. Sales of orga...four babies are growing up on daily helpings of th... appropriate labeling of baby food , came into for...
...a sudden emotional stress could weaken the heart. ...failure// in romance are said to be the triggering...archers at Johns Hopkins University found that sho...that mimic a serious heart attack causing severe h...
...nt officials that the much dreaded bird flu virus ... in UK//. The feral birds have the potential of po...urban areas, as they are susceptible to infection ...exact mechanism of how pigeons contract the infect...
Other Medicine News:
(Date:1/9/2009).../ -- ESBATech AG, a leading developer of antibody ...ion of the Phase I/IIa clinical development of its...arthritis (OA). This double-blind, randomized, pla...gned to investigate the safety, tolerability and e...ntra-articular administration to patients with sev...
(Date:1/8/2009)...wire-FirstCall/ -- , - ThromboGenics, Lead ...acular Adhesion in the US and Europe , Thro...logy company,focused on innovative treatments for...ces today that it has started the Phase III clinic...reatment of back of the eye disease, the,final st...
(Date:1/8/2009)...econd indication with clinical-stage, systemically...ONT, Calif., Jan. 8 Quark Pharmace...company discovering and developing novel RNA inter... that it has initiated patient dosing in its Phase...dministered siRNA drug candidate QPI-1002 (previou...
(Date:1/8/2009)...te Novel Gene Expression Biomarkers Involved in Wo...rm , , FREMONT, Calif., Jan. 8 /PRNewswire-Firs...Board: WGBS), a leading developer of state-of-the-...stem cell research systems, today announced the si...sity of Texas Southwestern Medical Center for the...
Breaking Medicine Technology:ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 2ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 3ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 4ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 2ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 3ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 4Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 2Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 3Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 2WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 3WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 5Media Affects Public Perception of Infectious Diseases 28442 1Media Affects Public Perception of Infectious Diseases 28442 2Senator Obama Explains His Health Care Plan to SpineUniverse com 28439 1Senator Obama Explains His Health Care Plan to SpineUniverse com 28439 2Senator Obama Explains His Health Care Plan to SpineUniverse com 28439 3Natural Hormone Balance 3A Gaining Ground in the Fight Against Breast Cancer 28436 1Natural Hormone Balance 3A Gaining Ground in the Fight Against Breast Cancer 28436 2If metastasectomy should be performed before other treatments 28433 1If metastasectomy should be performed before other treatments 28433 2
...tive lens delivering magnification of 2.0x, 2.5x a...f use. Movement whilst maintaining focal clarity i...The ultra lightweight aluminum bar and individual ...he mounted loupes and optimal focal alignment, eli...
...tive lens delivering magnification of 2.0x, 2.5x a...f use. Movement whilst maintaining focal clarity i...The ultra lightweight aluminum bar and individual ...he mounted loupes and optimal focal alignment, eli...
Utilized for capsulotomies, nucleus dislocating, and other intraocular applications. Formed (bent) cystitomes are angled to conform to the convexity of the lens, providing easier access to the anteri
23 gauge thin wall irrigation. 25 gauge thin wall aspiration. Angled 30 degree shaft 8 mm from tip to bend. Irrigation tip set 0.5 mm behind aspiration tip. Dual hub construction. Polished finish. Ov
Medicine Products: